Stilley William B. III has filed 3 insider transactions across 1 company since December 2022.
Most recent transaction: a grant/award of 240800 shares of ADIAL PHARMACEUTICALS, INC. ($ADIL) on May 23, 2023.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 23, 2023 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Stilley William B. III | Director | A | Common Stock | 240800 | $0.00 | 1,261,779.0000 | 26,463,559 | 23.59% | 0.91% |
| May 23, 2023 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Stilley William B. III | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |
| Dec. 30, 2022 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Stilley William B. III | Director | D | Common Stock | 166667 | $0.00 | 1,020,979.0000 | 1,028,982 | 14.03% | 16.20% |